Have you ever worried that, after long hours behind the wheel, factors like mental fatigue and physical exhaustion could slow your reactions—without you even realizing it? Or perhaps you’ve seen news reports about people with diabetes who have to prick their fingers every day to monitor their blood sugar—just thinking about it makes you cringe.

According to MemsConsulting, Honda’s R&D center in Japan has recently partnered with several leading Japanese universities and research institutions to develop sensing technology that enables drivers to autonomously monitor their own fatigue levels. The research team is currently working on a wearable biosensor composed of a microneedle array. Unlike conventional “bulky” designs, this sensor is… A microneedle patch that is even thinner than a needle and causes virtually no pain when used on the human body, its… The application scenarios are not limited to the automotive sector; they can also be extended to the health and medical field, such as helping diabetes patients monitor their blood glucose levels, thereby addressing multiple challenges in one go.

First, let’s talk about what this seemingly magical “microneedle” actually is. It’s not an injection, and it’s certainly not the kind of microneedling used in cosmetic procedures; rather, it is… An entire densely packed array of ultra‑small hollow needles. : Each individual filament is only a few millimeters long, with tips as fine as tens of microns, gently penetrating only the outermost layer of the skin and coming into contact with the cells surrounding it. Interstitial fluid is sufficient. Don’t underestimate interstitial fluid—it contains “body signals” virtually identical to those in blood: glucose, lactate, electrolytes, and hormones linked to stress, sleep, and alertness, all of which can be measured. It’s like attaching a miniaturized, minimally invasive, 24‑hour continuous physiological monitoring station right on your skin.

Why is Honda doing this? The answer is simple: driving safety.

Every year, there are millions of traffic accidents worldwide, many of which are linked to one issue: People feel tired and drowsy, experience high mental stress, and their attention starts to wander—yet the driver themselves may not even realize it.

Honda has long been developing in‑vehicle safety technologies, such as detecting driver fatigue through steering‑wheel movements and triggering an alert to prompt a stop for rest. However, engineers felt that this was still not enough: Could we let people know in advance that they’re “not feeling well,” rather than waiting for the car to alert them?

So, they set their sights on… Wearable biosensor The Honda engineer leading this research, who himself has a background in enzymology and biochemistry, stated: “Honda has long been focused on human–machine interaction; whether it’s cars, motorcycles, or future robots, they should…” Accurately understand the body’s condition. Meanwhile, microneedles are the most promising “human translators.”

What can this small patch detect?

The most remarkable feature of this microneedle sensor is its ability to simultaneously monitor multiple physiological parameters:

• Cortisol : Stress hormones, which indicate whether you are tense, anxious, or under stress.
• Melatonin : Regulates sleep and the circadian rhythm, telling you whether it’s time to feel sleepy or not.
• It can even monitor: Blood alcohol concentration

Simply put: Stick one on before you drive, and it will tell you straight away: “Your stress level is too high, your rhythm is off—driving could be dangerous. Take it easy.”

Moreover, compared with current detection methods, it offers clear advantages:

• Fast monitoring and rapid result presentation.
• Can be全程 Continuous monitoring , usable before boarding, during driving, and after getting off
• Almost painless and not off-putting.

Of course, the development of microneedle sensors also faces challenges; for instance, the correlation between analyte concentrations in cutaneous interstitial fluid and those in blood, as well as time lag, and the long-term stability of the sensor on the skin surface, all still require experimental optimization.

A “Gospel” for People with Diabetes

You may not know that, over the 30-year period from 1990 to 2020, the number of adult diabetes patients worldwide doubled. More than four times as much , now has already exceeded 825 million people 。

One of the most painful aspects of daily life for people with diabetes is… Repeated finger-prick blood sampling Although implantable glucose‑monitoring patches have since been developed, reducing pain, they still cause a foreign‑body sensation and must be replaced every one to two weeks, which is quite inconvenient. By contrast, this microneedle patch addresses these very pain points, truly representing “good news” for people with diabetes:

• Only the superficial layer of the skin is pierced, Almost painless
• The trauma is minimal, and it’s far more comfortable than deep implantation.
• The material is more stable and lasts longer.

It is electrically neutral, unlikely to trigger inflammation, and does not cause proteins or cells to adhere to its surface, exhibiting exceptional stability. It also contains substances such as glucose oxidase; when it encounters glucose in the interstitial fluid, a reaction occurs, enabling direct measurement of blood glucose levels. Currently, in mouse experiments, the results are comparable to those of conventional blood glucose monitoring. Highly consistent , reliability has been verified.

One of the key manufacturing processes for realizing microneedle biosensors is nanoimprint lithography.

To enable mass production of next-generation, high-sensitivity, multifunctional, low-cost microneedle biosensors, nanoimprint lithography is one of the key manufacturing processes.

• High Precision and Consistency: Nanoimprint lithography enables large‑area, high‑throughput fabrication of microneedle arrays with highly uniform dimensions and shapes, ensuring consistent puncturing performance and uniformity of drug‑loading and sensing regions at each needle tip—factors that are critical to sensor reliability.
• Fabrication of complex structures: It is possible to readily produce hollow microneedles (for extracting interstitial fluid), porous microneedles (for loading large amounts of drugs or sensing reagents), or microneedles with nanoscale surface textures or patterns (to enhance biomolecule immobilization or optical signal transduction)—all of which are difficult to achieve using conventional methods.
• High-throughput, low-cost potential: Once the master mold is fabricated, it can be rapidly replicated like stamping, making it well suited for mass production and reducing the manufacturing cost per sensor.
• Material compatibility: It can be used to process a variety of polymers (such as PMMA, hydrogels, etc.) and certain metallic materials—both of which are commonly employed in the fabrication of microneedles.

In the future, “microneedle patches” will become a part of everyday life.

In recent years, since the pandemic, people have become increasingly focused on remote health and at-home monitoring.

In the future, this type of microneedle biosensor will enable People with potential risks Identify problems in advance to enable early screening, early intervention, and early treatment.

From “cutting-edge in-car technology to prevent driver fatigue” and “a painless health device for blood glucose monitoring,” to a wearable health‑monitoring patch that could one day be accessible to everyone—nanoimprint lithography is making this invisible, ultra‑fine microneedle technology truly reach more people, quietly reshaping the way we communicate with our bodies. In the future, we may no longer have to rely on gut feelings to gauge whether we’re up to it; a tiny microneedle patch can gently yet precisely reveal the answer.